PSMA PET/CT imaging for biochemical recurrence of prostate cancer after radiotherapy: is it necessary to review the Phoenix criteria?

ConclusionsThe development of PSMA PET/CT questions the need for a review of the Phoenix criteria. Solid studies are needed to evaluate new PSA thresholds to redefine these criteria considering the clinical benefit to the patient of changing the therapeutic approach at different stages of the disease.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research